RSS Feed
Tags
adaptive trials advertising advisory committees best practices biologics biosimilar biotech BLA cancer Cato BioVentures Cato Research CBER CDER CDRH clinical trials CMC conference DDMAC DIA drug development eCTD efficacy FDA GlobalSubmit guest post guidance IND inspections medical devices NDA NIH nonclinical research oncology outsourcing personalized medicine postmarketing protocol safety slides Social Media statistical analysis transparency venture capital warning letters webinarCategories
Archives
Links
Follow us on Twitter!
- Featured yesterday at Fierce Biotech IT - Cato lists five keys to success in adaptive trials http://bit.ly/aHry0A about 17 hours ago from TweetDeck
- RT @reuters: "Outgunned FDA tries to get tough with drug ads" http://bit.ly/btorHn 08:45:47 PM September 07, 2010 from web
- @MicroConstants Thanks for retweeting! 07:27:43 PM September 07, 2010 from TweetDeckin reply to MicroConstants
- New blog post: August 2010 FDA Guidances - http://ask-cato.com/mg 02:50:26 PM September 07, 2010 from WordTwit Plugin
Author Archives: MegWalz
Cato Research Presents at NC East SoCRA Chapter Meeting
Cato Research Regulatory Scientist Amber Barnes, PhD, RAC will be speaking on “Informed Consent Content and Process Requirements” at the August 2, 2010 meeting of the NC East Chapter of the Society of Clinical Research Associates (SoCRA). Dr. Barnes’ presentation … Continue reading
Posted in Conferences and Meetings
1 Comment
Advice from the FDA, Part 2: Making Your eCTD Submission Reviewer-Friendly
Cato’s Director of Regulatory Operations, Evan Richardson, authored a guest blog post featured on PharmPro.com today. PharmPro.com is the website for Pharmaceutical Processing magazine, offering a wealth of information on products, technologies and applications for pharmaceutical and biopharmaceutical professionals. Evan’s … Continue reading
Advice for Sponsors New to eCTD
Recently, GlobalSubmit‘s Kathie Clark took an opportunity to sit down with Cato‘s Director of Regulatory Operations, Evan Richardson, and talk about Cato’s experience with sponsors who are new to eCTD submissions. Kathie published her interview with Evan this morning in … Continue reading
Free Webinar – Planning for FDA Clinical Site Inspections
Join Cato Research for a free educational webinar on Thursday 29 April 2010 at 2PM EST. Cato Research Regulatory Scientist Cathy Anderson will be presenting “Planning for FDA Clinical Site Inspections: Are You at Risk?” Topics covered will include: Responsibilities … Continue reading
Advice from the FDA, Part 1: Technical Errors to Avoid in Your eCTD Submissions
Cato’s Director of Regulatory Operations, Evan Richardson, authored a guest blog post featured on PharmPro.com today. PharmPro.com is the website for Pharmaceutical Processing magazine, offering a wealth of information on products, technologies and applications for pharmaceutical and biopharmaceutical professionals. Evan’s … Continue reading
Posted in Guest Posts, Publications, Social Media, eCTD
Tagged best practices, eCTD, FDA, guest post, PharmPro.com, submissions
Comments Off
